DENVER – Colorado will get more than $5 million from the makers of EpiPen. The drug company Mylan has been accused of charging the government an outrageous price for the potentially life-saving drug.
The federal government says the company was misinformed when it classified EpiPens as a generic medication to avoid having to pay rebates to Medicaid.
In August, Mylan agreed to pay a $465 million settlement, of which Colorado will receive $5.5 million. The money will be used for Colorado’s Medicaid program.
Read this story at CBS news.